To advance through public policy and advocacy activities the development of new antimicrobialagents where unmet need exists and the reduction of the occurrence of antimicrobial resistance;to make recommendations to the Board of Directors about how the Society can best further policy and advocacy efforts in these areas; to prioritize for government relations staff the federal funding needs; and to serve as IDSA’s primary point of contact for matters under its charge with Congress and the relevant federal agencies represented.
Barbara E. Murray, MD, FIDSA, PresidentUniversity of Texas Health Science CenterHouston, Texas
Amanda JezekVice President, Public Policy & Government Relations(703) 740-4790Fax: (866) 889-7319
John Billington, JD, MPHSenior Program Officer for Health Policy(703) 299-0015Fax: (866) 889-7319
To evaluate current trends related to the research, development, approval, manufacture, regulation and uptake of infectious diseases diagnostics at a time of rapid evolvement in the field; to assess and prioritize unmet diagnostics needs (including for clinical, public health, and global health purposes), particularly in the area of point-of-care diagnostics, and determine the degree of misalignment with current trends; to understand the challenges to diagnostics innovation and uptake from the perspective of key stakeholders (industry, governments, health care providers and payors/funders) and consider potential policy options for overcoming these challenges; and to make recommendations to the Board of Directors on policy solutions that will improve the U.S. government’s capacity to address unmet diagnostics needs in this country as well as in resource-constrained countries.
Angela M. Caliendo, MD, PhD, FIDSAEmory University HospitalAtlanta, GA
Gregory Frank, PhDProgram Officer for Science & Research PolicyPhone: (703) 299-1216Fax: (866) 889-7319
To serve as the lead entity making recommendations to the Board of Directors on public health and emergency preparedness policy, including issues and policy related to emerging infections and biothreats, seasonal and pandemic influenza, food-borne illnesses; and to use of antimicrobials in agriculture. Although primarily focused on domestic public health matters—global health will be considered where it intersect with IDSA’s public health and emergency preparedness policy agenda; to advise policymakers about policy and funding opportunities related to surveillance, capacities- and infrastructure-building, and countermeasures research and development; to prioritize for government relations staff the federal funding needs in these areas; and to serve as IDSA’s primary point of contact for matters under its charge with relevant federal agencies.
Jeffrey S. Duchin, MD, FIDSAPublic Health SeattleSeattle, WA
To make recommendations to promote research and new advancements in infectious diseases; to monitor developments and make recommendations related to federal support for biomedical research; and to make recommendations on activities/issues under its purview that involve federal legislation and regulation.
Ebbing Lautenbach, MD, FIDSA, ChairUniversity of Pennsylvania School of MedicinePhiladelphia, PA
Gregory Frank, PhD Program Officer for Science & Research Policy Phone: 703-299-1216 Fax: 866-889-7319
Antimicrobial Resistant Infections
Antimicrobial Resistant Topic of Interest
Influenza and Bio-Threats
Global Health Policy
1300 Wilson Boulevard Suite 300 Arlington, VA 22209 | Phone: (703) 299-0200 | Fax: (703) 299-0204
| HIVMA | Contact Us
© Copyright IDSA 2016 Infectious Diseases Society of America